Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Kratzer

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Frontiers in Immunology|January 26, 2023
The frequency of differentiated CD3<sup>+</sup>CD27<sup>-</sup>CD28<sup>-</sup> T cells predicts response to CART cell therapy in diffuse large B-cell lymphomaNina Worel, Katharina Grabmeier-Pfistershammer, Bernhard Kratzer, et al.
Allergy|June 12, 2022
Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post-infection and post-vaccination cellular SARS-CoV-2-specific immune responseBernhard Kratzer, Larissa C Schlax, Pia Gattinger, et al.
Allergy|August 28, 2021
Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopesPia Gattinger, Katarzyna Niespodziana, Karin Stiasny, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Frontiers in Immunology|January 26, 2023
The frequency of differentiated CD3<sup>+</sup>CD27<sup>-</sup>CD28<sup>-</sup> T cells predicts response to CART cell therapy in diffuse large B-cell lymphomaNina Worel, Katharina Grabmeier-Pfistershammer, Bernhard Kratzer, et al.
Allergy|June 12, 2022
Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post-infection and post-vaccination cellular SARS-CoV-2-specific immune responseBernhard Kratzer, Larissa C Schlax, Pia Gattinger, et al.
Allergy|August 28, 2021
Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopesPia Gattinger, Katarzyna Niespodziana, Karin Stiasny, et al.
Pageof 4